199 related articles for article (PubMed ID: 15835267)
1. Chromosomal instability in meningiomas.
van Tilborg AA; Al Allak B; Velthuizen SC; de Vries A; Kros JM; Avezaat CJ; de Klein A; Beverloo HB; Zwarthoff EC
J Neuropathol Exp Neurol; 2005 Apr; 64(4):312-22. PubMed ID: 15835267
[TBL] [Abstract][Full Text] [Related]
2. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
3. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal involvement secondary to -22 in human meningiomas.
Rey JA; Bello MJ; de Campos JM; Kusak E; Moreno S
Cancer Genet Cytogenet; 1988 Jul; 33(2):275-90. PubMed ID: 3383169
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
6. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
7. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
11. Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype.
Prowald A; Wemmert S; Biehl C; Storck S; Martin T; Henn W; Ketter R; Meese E; Zang KD; Steudel WI; Urbschat S
Int J Oncol; 2005 Feb; 26(2):385-93. PubMed ID: 15645123
[TBL] [Abstract][Full Text] [Related]
12. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases.
Zang KD
Cytogenet Cell Genet; 2001; 93(3-4):207-20. PubMed ID: 11528114
[TBL] [Abstract][Full Text] [Related]
13. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for chromosome 22 DNA sequences in human meningioma.
Cogen PH; Daneshvar L; Bowcock AM; Metzger AK; Cavalli-Sforza LL
Cancer Genet Cytogenet; 1991 Jun; 53(2):271-7. PubMed ID: 1676608
[TBL] [Abstract][Full Text] [Related]
17. Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.
Ketter R; Kim YJ; Storck S; Rahnenführer J; Romeike BF; Steudel WI; Zang KD; Henn W
J Neurooncol; 2007 Jun; 83(2):213-21. PubMed ID: 17225936
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of meningiomas.
Ragel BT; Jensen RL
Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
[TBL] [Abstract][Full Text] [Related]
19. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of beta-catenin/E-cadherin in meningiomas.
Brunner EC; Romeike BF; Jung M; Comtesse N; Meese E
Histopathology; 2006 Aug; 49(2):178-87. PubMed ID: 16879395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
